Peregrine flies with positive Phase II bavituximab lung cancer data
07 December 2011
Pial Ganguli
Please Login to read the full article.
07 December 2011
Pial Ganguli
Please Login to read the full article.
RELATED CONTENT
NEWS
- Peregrine rises on "robust" Phase IIb second-line NSCLC data
- Peregrine upbeat on Phase II bavituximab breast cancer survival data
- AVEO's unconvincing Phase II ficlatuzumab data point to need for further studies
- Sanofi/Regeneron's Zaltrap fails in third oncology indication - prostate cancer
ANALYSIS
Other Informa Analysis
EVENTS
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
